Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712704 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Analytical Tool - Cancer Therapeutic Antibodies -' returned 110 results - Page 1 of 6

 FEATURED RESULTS
Drug Delivery in Cancer - Technologies, Markets and Companies

Antibody Drug Target Atlas in Oncology

Cancer Diagnostic Testing World Markets

Cancer and its Management, 6th Edition

Outcome Prediction in Cancer


  Sort by   
  Sorted by Rank Top-Bottom

Analytical Tool - Cancer Therapeutic Antibodies  
Bioseeker, Sep 2011
"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment


Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies  
Bioseeker, June 2006
"Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody R


Triple Analysis: Breast Cancer, Cancer Vaccines and Antibodies  
Bioseeker, Sep 2011, Pages: 3516
publication: Portfolio Analytics and Planning in the Breast Cancer Pipeline - Change is Around the Corner in a Highly Competitive Market Place Part II: Cancer Vaccines The cancer vaccine report part comprises


Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Antibodies  
Bioseeker, Sep 2011, Pages: 3213
Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs in oncology within the portfolio


Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies  
Bioseeker, Sep 2011, Pages: 3926
is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Cancer Vaccines The cancer vaccine report part comprises defined


Triple Analysis: Breast Cancer, Lung Cancer and Antibodies  
Bioseeker, Sep 2011, Pages: 4180
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the compound strategy of Antibodies. Each of these three individual parts is evaluated


Triple Analysis: Prostate Cancer, Cancer Vaccines and Antibodies  
Bioseeker, Sep 2011, Pages: 3441
on the following publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market Part II: Cancer Vaccines The cancer vaccine report part comprises defined


Triple Analysis: Lung Cancer, Pancreatic Cancer and Antibodies  
Bioseeker, Sep 2011, Pages: 3877
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the compound strategy of Antibodies. Each of these three individual parts


Triple Analysis: Colorectal Cancer, Cancer Vaccines and Antibodies  
Bioseeker, Sep 2011, Pages: 3659
Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs in oncology within the portfolio


Triple Analysis: Breast Cancer, Prostate Cancer and Antibodies  
Bioseeker, Sep 2011, Pages: 3695
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the compound strategy of Antibodies. Each of these three individual parts


Triple Analysis: Breast Cancer, Colorectal Cancer and Antibodies  
Bioseeker, Sep 2011, Pages: 3913
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Colorectal Cancer and by the compound strategy of Antibodies. Each of these three individual parts


Triple Analysis: Pancreatic Cancer, Prostate Cancer and Antibodies  
Bioseeker, Sep 2011, Pages: 3392
This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the compound strategy of Antibodies. Each of these three individual parts


Triple Analysis: Lung Cancer, Prostate Cancer and Antibodies  
Bioseeker, Sep 2011, Pages: 4105
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the compound strategy of Antibodies. Each of these three individual parts


Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Antibodies  
Bioseeker, Sep 2011, Pages: 3610
This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer and by the compound strategy of Antibodies. Each of these three individual parts


Triple Analysis: Colorectal Cancer, Lung Cancer and Antibodies  
Bioseeker, Sep 2011, Pages: 4323
This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the compound strategy of Antibodies. Each of these three individual parts


Triple Analysis: Colorectal Cancer, Prostate Cancer and Antibodies  
Bioseeker, Sep 2011, Pages: 3838
This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the compound strategy of Antibodies. Each of these three individual parts


The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others  
Bioseeker, Sep 2011, Pages: 1944
in the Cancer Gene Census and in the Catalogue of Somatic Mutations in Cancer 6.4 Antibody Therapeutics is Stimulated by Available Structure Data on Biological Targets 6.5 Target-Target Interactions among


Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Antibodies  
Bioseeker, Sep 2011, Pages: 4709
: Protein Kinase Therapeutics in Oncology - Where to Commercialize? Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs


Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Antibodies  
Bioseeker, Sep 2011, Pages: 4045
: Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part II: Protein Kinase Inhibitors The protein kinase report comprises defined and up to date development strategies for 409


Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies  
Bioseeker, Sep 2011, Pages: 4224
Therapeutics in Oncology - Where to Commercialize? Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs in oncology within


Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds